Am Heart J. 2021 Mar 18:S0002-8703(21)00076-4. doi: 10.1016/j.ahj.2021.03.010. Online ahead of print.
ABSTRACT
Patients with coronavirus disease 2019 (COVID-19) are at heightened risk of venous thromboembolic events (VTE), though there is no data examining when these events occur following a COVID-19 diagnosis. We therefore sought to characterize the incidence, timecourse of events, and outcomes of VTE during the COVID-19 pandemic in a national healthcare system using data from Veterans Affairs Administration.
PMID:33745899 | DOI:10.1016/j.ahj.2021.03.010